25 results
Treatment Algorithm for First Time Pulmonary Embolism
 • Provoked
 • Unprovoked
 • Active Malignancy

By Carlin Rooke,
Treatment Algorithm ... for First Time Pulmonary ... #PE #Pulmonary # ... Embolism #Treatment ... #hematology #VTE
Infographic depicting the main pearls of various types of congenital adrenal hyperplasia for the medical student.
#CAH #algorithm ... diagnosis #comparison #treatment ... #Peds #Endocrinology ... #Adrenal #pathophysiology
Tetralogy of Fallot Summary
 • Anatomy
 • Incidence
 • Pathophysiology
 • Presentation
 • Common Variants
 •
• Incidence • Pathophysiology ... diagnosis #management #cardiology ... #peds #pediatrics ... #treatment
Algorithm for Treatment of Chronic Thromboembolic Disease (CTEPH)
Initial Imaging for Screening - V/Q scan - 90-100%
Algorithm for Treatment ... • Assess for Pulmonary ... cteph #management #algorithm ... #cardiology #pulmonary ... #treatment
Total Anomalous Pulmonary Venous Return (TAPVR)
 • Introduction
 • Classification
 • Pathophysiology of TAPVR
 • Presentation
Total Anomalous Pulmonary ... Classification • Pathophysiology ... Total #Anomalous #Pulmonary ... diagnosis #management #cardiology ... #peds #pediatrics
Truncus Arteriosus
 • Basic Information
 • Embryology
 • Associated anomalies
 • Pathophysiology/Presentation
 • Pre-operative management
 •
anomalies • Pathophysiology ... Cardiomegaly, increased pulmonary ... diagnosis #management #cardiology ... #peds #pediatrics
Petechiae/Purpura - Diagnostic Algorithm. Pathophysiology: 1) Represent the passage of erythrocytes from the intravascular to extravascular
Purpura - Diagnostic Algorithm ... Pathophysiology: ... commonly renal and pulmonary ... #Diagnosis #Dermatology ... Purpura #Palpable #Algorithm
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
#management #algorithm ... #pharmacology #treatment ... #decisionaid #cardiology ... #hematology #warfarin
TRALI vs TACO - Transfusion Reactions
TRALI:
 • Epidemiology: 0.1% of transfused patientsl
 • Risk factors: Critical
blood donor • Pathophysiology ... : 33% • Treatment ... , and CXR with pulmonary ... : No • Treatment ... Transfusion #Reactions #hematology
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
stratification algorithm ... for the treatment ... thrombosis; PE = pulmonary ... Malignancy #Cancer #Algorithm ... Anticoagulation #Management #Hematology